The effect of social defeat on tyrosine hydroxylase phosphorylation in the rat brain and adrenal gland.
Tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine biosynthesis, is regulated acutely by protein phosphorylation and chronically by protein synthesis. No studies have systematically investigated the phosphorylation of these sites in vivo in response to stressors. We specifically investigated the phosphorylation of TH occurring within the first 24 h in response to the social defeat stress in the rat adrenal, the locus coeruleus, substantia nigra and ventral tegmental area. Five groups were investigated; home cage control (HCC), two groups that underwent social defeat (SD+) which were sacrificed either 10 min or 24 h after the end of the protocol and two groups that were put into the cage without the resident being present (SD-) which were sacrificed at time points identical to the SD+. We found at 10 min there were significant increases in serine 40 and 31 phosphorylation levels in the locus coeruleus in SD+ compared to HCC and increases in serine 40 phosphorylation levels in the substantia nigra in SD+ compared to SD-. We found at 24 h there were significant increases in serine 19 phosphorylation levels in the ventral tegmental area in SD+ compared to HCC and decreases in serine 40 phosphorylation levels in the adrenal in SD+ compared to SD-. These findings suggest that the regulation of TH phosphorylation in different catecholamine-producing cells varies considerably and is dependent on both the nature of the stressor and the time at which the response is analysed.
Ong
Lin Kooi
LK
School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW 2308, Australia.
Bobrovskaya
Larisa
L
Walker
Frederick R
FR
Day
Trevor A
TA
Dickson
Phillip W
PW
Dunkley
Peter R
PR
D000311:Adrenal Glands / Q000378:metabolism*; D000374:Aggression / Q000502:physiology; D000818:Animals; D002395:Catecholamines / Q000378:metabolism; D008125:Locus Coeruleus / Q000166:cytology / Q000378:metabolism*; D008297:Male; D010766:Phosphorylation; D051381:Rats; D017207:Rats, Sprague-Dawley; D012919:Social Behavior; D013378:Substantia Nigra / Q000166:cytology / Q000378:metabolism*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*; D017557:Ventral Tegmental Area / Q000166:cytology / Q000378:metabolism*
D002395:Catecholamines; D014446:Tyrosine 3-Monooxygenase
J Neurochem. 1992 Jan;58(1):57-64
1345770
J Biol Chem. 1991 Mar 25;266(9):5650-7
1672315
J Neurochem. 2004 Dec;91(5):1025-43
15569247
Pharmacol Ther. 1995;68(2):297-42
8719972
Acta Physiol Scand. 2000 Jan;168(1):1-17
10691773
Methods Mol Biol. 1995;41:239-59
7655560
Stress. 2002 Dec;5(4):277-83
12475732
Neuroscience. 2009 Jun 16;161(1):3-12
19298844
J Biol Chem. 1964 Sep;239:2910-7
14216443
Annu Rev Neurosci. 1989;12:415-61
2564757
Endocr Rev. 2001 Aug;22(4):502-48
11493581
Neuroendocrinology. 2004;80(1):42-51
15345906
Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2365-9
1347949
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Dec;29(8):1214-24
16226365
J Neurochem. 2000 Jul;75(1):225-32
10854265
J Neurochem. 1996 Aug;67(2):443-62
8764568
Cell Signal. 2007 Jun;19(6):1141-9
17261361
Acta Physiol Scand Suppl. 1997;640:69-72
9401610
Science. 1984 May 4;224(4648):452-9
6143403
Brain Res. 1993 Apr 16;608(2):310-8
8495365
Neurochem Int. 2010 Sep;57(2):162-7
20493917
Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5937-41
7912437
J Neurochem. 2007 Jan;100(2):479-89
17064352
Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):891-900
16645894
J Neurochem. 2002 Jul;82(2):382-8
12124439
Mol Pharmacol. 1994 Dec;46(6):1041-7
7808423
Neuroscience. 2009 Aug 18;162(2):244-53
19393295
J Neurochem. 1990 May;54(5):1769-75
1691281
Biochim Biophys Acta. 2009 Dec;1793(12):1860-7
19833152